,0
zip,10591-6707
sector,Healthcare
fullTimeEmployees,10368
longBusinessSummary,"Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York."
city,Tarrytown
phone,914 847 7000
state,NY
country,United States
companyOfficers,[]
website,https://www.regeneron.com
maxAge,1
address1,777 Old Saw Mill River Road
industry,Biotechnology
ebitdaMargins,0.57449
profitMargins,0.50245
grossMargins,0.66739
operatingCashflow,7081299968
revenueGrowth,1.044
operatingMargins,0.55667996
ebitda,9233000448
targetLowPrice,570
recommendationKey,buy
grossProfits,10726100000
freeCashflow,4279237376
targetMedianPrice,705
currentPrice,680.03
earningsGrowth,0.923
currentRatio,3.564
returnOnAssets,0.26253
numberOfAnalystOpinions,25
targetMeanPrice,715.68
debtToEquity,14.384
returnOnEquity,0.54207003
targetHighPrice,850
totalCash,5694700032
totalDebt,2699699968
totalRevenue,16071700480
totalCashPerShare,53.502
financialCurrency,USD
revenuePerShare,152.05
quickRatio,2.983
recommendationMean,2.1
exchange,NMS
shortName,"Regeneron Pharmaceuticals, Inc."
longName,"Regeneron Pharmaceuticals, Inc."
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,True
gmtOffSetMilliseconds,-14400000
underlyingSymbol,
quoteType,EQUITY
symbol,REGN
underlyingExchangeSymbol,
headSymbol,
messageBoardId,finmb_33715
uuid,e55aa808-7510-354a-9528-01782e66194d
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,3.922
beta3Year,
enterpriseToEbitda,6.828
52WeekChange,
morningStarRiskRating,
forwardEps,47.81
revenueQuarterlyGrowth,
sharesOutstanding,105720000
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,163.522
sharesShort,2138019
sharesPercentSharesOut,0.0197
fundFamily,
lastFiscalYearEnd,1640908800
heldPercentInstitutions,0.86867
netIncomeToCommon,8075299840
trailingEps,62.526
lastDividendValue,
SandP52WeekChange,
priceToBook,4.1586456
heldPercentInsiders,0.02961
nextFiscalYearEnd,1703980800
yield,
mostRecentQuarter,1640908800
shortRatio,2.38
sharesShortPreviousMonthDate,1642118400
floatShares,101430249
beta,0.184547
enterpriseValue,63040995328
priceHint,2
threeYearAverageReturn,
lastSplitDate,
lastSplitFactor,
legalType,
morningStarOverallRating,
earningsQuarterlyGrowth,0.94
priceToSalesTrailing12Months,4.5503874
dateShortInterest,1644883200
pegRatio,0.67
ytdReturn,
forwardPE,14.223594
lastCapGain,
shortPercentOfFloat,0.023599999
sharesShortPriorMonth,1815041
category,
fiveYearAverageReturn,
previousClose,679.76
regularMarketOpen,679.9
twoHundredDayAverage,615.21423
trailingAnnualDividendYield,
payoutRatio,0
volume24Hr,
regularMarketDayHigh,685.01
navPrice,
averageDailyVolume10Day,725340
regularMarketPreviousClose,679.76
fiftyDayAverage,630.4354
trailingAnnualDividendRate,
open,679.9
averageVolume10days,725340
expireDate,
algorithm,
dividendRate,
exDividendDate,
circulatingSupply,
startDate,
regularMarketDayLow,676.21
currency,USD
trailingPE,10.875956
regularMarketVolume,366801
lastMarket,
maxSupply,
openInterest,
marketCap,73132466176
volumeAllCurrencies,
strikePrice,
averageVolume,725747
dayLow,676.21
ask,679.95
askSize,800
volume,366801
fiftyTwoWeekHigh,697.01
fromCurrency,
fiveYearAvgDividendYield,
fiftyTwoWeekLow,469.36
bid,669.01
tradeable,False
dividendYield,
bidSize,1000
dayHigh,685.01
regularMarketPrice,680.03
preMarketPrice,
logo_url,https://logo.clearbit.com/regeneron.com
